The Filings Report

CoreWeave

CRWVNasdaqCIK 1769628Technology / Softwarefiscal year ends December10 quarters since 2024

Revenue, Q2 FY2026
$2.6B
+112.5% on Q2 FY2025
Net income
−$626M
−115.9% on Q2 FY2025
Free cash flow
−$5.7B
−112.4% on Q2 FY2025
Diluted EPS
$-1.14
−90.0% on Q2 FY2025
Revenue, TTM
$7.6B
trailing four quarters
Net margin, TTM
-25.4%
net income −$1.9B
Free cash flow, TTM
−$13.7B
$6.9B less $20.6B capex
Cash and equivalents
$5.5B
long-term debt —, Jun 30, 2026
Shares, 12-month change
—
— shares, Jun 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
—
no yield
Market value
—
at the close, buybacks

Latest quarter Q2 FY2026, filed August 12, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, CoreWeave reported revenue of $2.6B, +112.5% on Q2 FY2025, and net loss of $626M (−115.9%). Net income this quarter is driven by non-operating items: $125M of other income against −$49M of operating income, so it reflects gains or losses outside the operations. Operating margin was −1.9%. Free cash flow, operating cash flow less capital expenditures, was −$5.7B ($679M less $6.4B). Diluted earnings per share were $-1.14.

The last 10 quarters

Q1 FY2024 to Q2 FY2026, through the filing of August 12, 2026.

Revenue and net incomeRevenueNet income
−$1B$0$1B$2B$3BQ1'24, Revenue: $189MQ1'24, Net income: −$129MQ1'24Q2'24, Revenue: $395MQ2'24, Net income: −$323MQ2'24Q3'24, Revenue: $584MQ3'24, Net income: −$360MQ3'24Q4'24, Revenue: $747MQ4'24, Net income: −$51MQ4'24Q1'25, Revenue: $982MQ1'25, Net income: −$315MQ1'25Q2'25, Revenue: $1.2BQ2'25, Net income: −$290MQ2'25Q3'25, Revenue: $1.4BQ3'25, Net income: −$110MQ3'25Q4'25, Revenue: $1.6BQ4'25, Net income: −$452MQ4'25Q1'26, Revenue: $2.1BQ1'26, Net income: −$740MQ1'26Q2'26, Revenue: $2.6BQ2'26, Net income: −$626MQ2'26−$1B$0$1B$2B$3BQ1'24, Revenue: $189MQ1'24, Net income: −$129MQ1'24Q2'24, Revenue: $395MQ2'24, Net income: −$323MQ2'24Q3'24, Revenue: $584MQ3'24, Net income: −$360MQ3'24Q4'24, Revenue: $747MQ4'24, Net income: −$51MQ4'24Q1'25, Revenue: $982MQ1'25, Net income: −$315MQ1'25Q2'25, Revenue: $1.2BQ2'25, Net income: −$290MQ2'25Q3'25, Revenue: $1.4BQ3'25, Net income: −$110MQ3'25Q4'25, Revenue: $1.6BQ4'25, Net income: −$452MQ4'25Q1'26, Revenue: $2.1BQ1'26, Net income: −$740MQ1'26Q2'26, Revenue: $2.6BQ2'26, Net income: −$626MQ2'26

Net income losses drawn in red.

Free cash flow
−$6B−$4B−$2B$0$2BQ1'24, Free cash flow: $297MQ1'24Q2'24, Free cash flow: −$2.4BQ2'24Q3'24, Free cash flow: −$574MQ3'24Q4'24, Free cash flow: −$3.3BQ4'24Q1'25, Free cash flow: −$1.3BQ1'25Q2'25, Free cash flow: −$2.7BQ2'25Q3'25, Free cash flow: −$700MQ3'25Q4'25, Free cash flow: −$2.5BQ4'25Q1'26, Free cash flow: −$4.7BQ1'26Q2'26, Free cash flow: −$5.7BQ2'26−$6B−$4B−$2B$0$2BQ1'24, Free cash flow: $297MQ1'24Q2'24, Free cash flow: −$2.4BQ2'24Q3'24, Free cash flow: −$574MQ3'24Q4'24, Free cash flow: −$3.3BQ4'24Q1'25, Free cash flow: −$1.3BQ1'25Q2'25, Free cash flow: −$2.7BQ2'25Q3'25, Free cash flow: −$700MQ3'25Q4'25, Free cash flow: −$2.5BQ4'25Q1'26, Free cash flow: −$4.7BQ1'26Q2'26, Free cash flow: −$5.7BQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15B$20BQ1'24, Cash and equivalents: $1.3BQ1'24Q2'24, Cash and equivalents: $1.0BQ2'24Q3'24, Cash and equivalents: $1.4BQ3'24Q4'24, Cash and equivalents: $1.4BQ4'24, Long-term debt: $5.5BQ4'24Q1'25, Cash and equivalents: $1.3BQ1'25, Long-term debt: $4.9BQ1'25Q2'25, Cash and equivalents: $1.2BQ2'25, Long-term debt: $7.4BQ2'25Q3'25, Cash and equivalents: $1.9BQ3'25, Long-term debt: $10.3BQ3'25Q4'25, Cash and equivalents: $3.1BQ4'25, Long-term debt: $14.7BQ4'25Q1'26, Cash and equivalents: $2.2BQ1'26, Long-term debt: $17.3BQ1'26Q2'26, Cash and equivalents: $5.5BQ2'26$0$5B$10B$15B$20BQ1'24, Cash and equivalents: $1.3BQ1'24Q2'24, Cash and equivalents: $1.0BQ2'24Q3'24, Cash and equivalents: $1.4BQ3'24Q4'24, Cash and equivalents: $1.4BQ4'24, Long-term debt: $5.5BQ4'24Q1'25, Cash and equivalents: $1.3BQ1'25, Long-term debt: $4.9BQ1'25Q2'25, Cash and equivalents: $1.2BQ2'25, Long-term debt: $7.4BQ2'25Q3'25, Cash and equivalents: $1.9BQ3'25, Long-term debt: $10.3BQ3'25Q4'25, Cash and equivalents: $3.1BQ4'25, Long-term debt: $14.7BQ4'25Q1'26, Cash and equivalents: $2.2BQ1'26, Long-term debt: $17.3BQ1'26Q2'26, Cash and equivalents: $5.5BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 12, 2026.

CoreWeave income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 12, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Mar 2, 2026Q3 FY2025ended Sep 30, 2025filed Nov 13, 2025Q2 FY2025ended Jun 30, 2025filed Aug 13, 2025Q1 FY2025ended Mar 31, 2025filed May 15, 2025Q4 FY2024ended Dec 31, 2024filed May 15, 2025Q3 FY2024ended Sep 30, 2024filed Nov 13, 2025YoYQ2 FY2026vs Q2 FY2025
Revenue2,5752,0781,5721,3651,212982747584+112.5%
Cost of revenue879716509369313262182143+180.8%
Gross profit—————————
Research and development1171041099380702114+46.3%
Selling, general and administrative1781641501521741754834+2.3%
Operating income(49)(144)(90)5219(27)112117−357.9%
Other income (expense)1252410226(5)1510+1983.3%
Pretax income(564)(656)(467)(237)(242)(269)(29)(318)−133.1%
Income tax6284(15)(127)48462242+29.2%
Net income(626)(740)(452)(110)(290)(315)(51)(360)−115.9%
Diluted EPS ($)(1.14)(1.40)—(0.22)(0.60)(1.49)—(1.82)−90.0%
Diluted shares (millions)551527—498487249—214—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 12, 2026.

CoreWeave balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 12, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Mar 2, 2026Q3 FY2025ended Sep 30, 2025filed Nov 13, 2025Q2 FY2025ended Jun 30, 2025filed Aug 13, 2025Q1 FY2025ended Mar 31, 2025filed May 15, 2025Q4 FY2024ended Dec 31, 2024filed May 15, 2025Q3 FY2024ended Sep 30, 2024filed Nov 13, 2025YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents5,5242,2443,1271,8941,1531,2761,3611,355+379.1%
Short-term investments15223447——0——
Total current assets9,5205,6097,4884,7313,9463,1031,916—+141.3%
Total assets77,07055,57349,30232,91026,24121,86017,833—+193.7%
Total current liabilities20,91717,81816,4409,7157,5567,1314,963—+176.8%
Long-term debt—17,31214,66510,3237,4244,9355,458——
Total liabilities72,04650,81445,96729,03222,42118,79116,525—+221.3%
Stockholders’ equity5,0244,7593,3353,8782,6581,906(414)(344)+89.0%
Shares outstanding (millions)—————————

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 12, 2026.

CoreWeave cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 12, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Mar 2, 2026Q3 FY2025ended Sep 30, 2025filed Nov 13, 2025Q2 FY2025ended Jun 30, 2025filed Aug 13, 2025Q1 FY2025ended Mar 31, 2025filed May 15, 2025Q4 FY2024ended Dec 31, 2024filed May 15, 2025Q3 FY2024ended Sep 30, 2024filed Nov 13, 2025YoYQ2 FY2026vs Q2 FY2025
Operating cash flow6792,9841,5591,689(251)61187641+370.5%
Capital expenditures6,4227,6954,0602,3892,4531,4073,4981,215+161.8%
Free cash flow (CFO − capex)(5,743)(4,711)(2,501)(700)(2,704)(1,346)(3,311)(574)−112.4%
Depreciation and amortization1,3931,147821630560443365254+148.8%
Share repurchases—————————
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed March 2, 2026.

Income statement

CoreWeave income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Mar 2, 2026FY2024ended Dec 31, 2024filed May 15, 2025FY2023ended Dec 31, 2023filed May 15, 2025
Revenue5,1311,915229
Cost of revenue1,45349369
Gross profit———
Research and development3525621
Selling, general and administrative65111930
Operating income(46)324(14)
Other income (expense)334918
Pretax income(1,215)(744)(558)
Income tax(48)11936
Net income(1,167)(863)(594)
Diluted EPS ($)(2.81)(4.30)(3.09)
Diluted shares (millions)436218192

Balance sheet

CoreWeave balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Mar 2, 2026FY2024ended Dec 31, 2024filed May 15, 2025FY2023ended Dec 31, 2023filed May 15, 2025
Cash and equivalents3,1271,361217
Short-term investments340—
Total current assets7,4881,916—
Total assets49,30217,833—
Total current liabilities16,4404,963—
Long-term debt14,6655,458—
Total liabilities45,96716,525—
Stockholders’ equity3,335(414)(597)
Shares outstanding (millions)———

Cash flow statement

CoreWeave cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Mar 2, 2026FY2024ended Dec 31, 2024filed May 15, 2025FY2023ended Dec 31, 2023filed May 15, 2025
Operating cash flow3,0582,7491,833
Capital expenditures10,3098,7022,943
Free cash flow (CFO − capex)(7,251)(5,953)(1,110)
Depreciation and amortization2,454863103
Share repurchases———
Dividends paid———

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$917M
503 sales by 10 insiders; officers and directors $405M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$5.3B
3205 sales by 13 insiders; officers and directors $2.8B

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 29, 2026Baker JeffPrincipal Accounting Officeroption exercise12,500——20,840Oct 30, 2026
Oct 29, 2026Baker JeffPrincipal Accounting Officeropen-market sale258$61.69$16K20,582Oct 30, 2026
Oct 29, 2026Baker JeffPrincipal Accounting Officeropen-market sale6,412$61.14$392K14,170Oct 30, 2026
Oct 20, 2026Whitman Margaret CDirectoraward122$0.00—7,922Oct 22, 2026
Oct 20, 2026Hutchins Glenn HDirectoraward320$0.00—11,643Oct 22, 2026
Oct 13, 2026Jones JonathanChief Revenue Officeropen-market sale10b5-115,100$77.18$1M11,861Oct 14, 2026
Oct 13, 2026Jones JonathanChief Revenue Officeropen-market sale10b5-15,969$77.92$465K5,892Oct 14, 2026
Oct 13, 2026Jones JonathanChief Revenue Officeropen-market sale10b5-1500$78.74$39K5,392Oct 14, 2026
Oct 12, 2026Agrawal NitinChief Financial Officeropen-market sale10b5-115,388$79.95$1M117,208Oct 14, 2026
Oct 12, 2026Agrawal NitinChief Financial Officeropen-market sale10b5-17,191$80.51$579K110,017Oct 14, 2026
Oct 12, 2026Jones JonathanChief Revenue Officeropen-market sale10b5-115,811$80.36$1M26,961Oct 14, 2026
Oct 11, 2026Jones JonathanChief Revenue Officeroption exercise42,772——42,772Oct 14, 2026
Oct 6, 2026Boone KarenDirectoroption exercise1,460——10,240Oct 8, 2026
Oct 6, 2026Agrawal NitinChief Financial Officeropen-market sale10b5-13$88.60$266132,596Oct 8, 2026
Sep 30, 2026Venturo Brian MChief Strategy Officer, Directoroption exercise109,380——350,751Oct 2, 2026
Sep 30, 2026Venturo Brian MChief Strategy Officer, Directoroption exercise17,391——368,142Oct 2, 2026
Sep 30, 2026Venturo Brian MChief Strategy Officer, Directoropen-market sale65,616$87.69$6M302,526Oct 2, 2026
Sep 30, 2026McVeety Kristen JGC and Secretaryoption exercise8——123,321Oct 2, 2026
Sep 30, 2026McVeety Kristen JGC and Secretaryopen-market sale5$87.69$438123,316Oct 2, 2026
Sep 30, 2026McBee BranninChief Development Officeroption exercise109,380——437,071Oct 2, 2026
Sep 30, 2026McBee BranninChief Development Officeroption exercise11,739——448,810Oct 2, 2026
Sep 30, 2026McBee BranninChief Development Officeropen-market sale56,531$87.69$5M392,279Oct 2, 2026
Sep 30, 2026Jain SachinChief Operating Officeroption exercise8——157,099Oct 2, 2026
Sep 30, 2026Jain SachinChief Operating Officeropen-market sale4$87.69$351157,095Oct 2, 2026
Sep 30, 2026Intrator Michael NCEO and President, Director, 10% owneroption exercise109,380——596,509Oct 2, 2026

Full insider history for CoreWeave, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

2 of the tracked managers held CRWV in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded CRWV by quarter.

FundManagerQuarterValueSharesWeightMove
Altimeter CapitalBrad GerstnerQ2 2026$605M6M6.15%added +35.0%
Appaloosa ManagementDavid TepperQ2 2026$107M1M1.39%new

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
CoreWeave, Inc., CIK 1769628 on EDGAR
Extract generated
August 28, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: not filed
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): not filed

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated August 28, 2026.

JSON file
/data/financials/CRWV.json